NeurologyLive® Friday 5 — October 30, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!

Click the read more or watch now buttons for more details and information about each highlight.

1: Advancing Biomarkers for Cerebral Small Vessel Disease Trials: Joanna Wardlaw, MD

In a recent WSC 2026 interview, Joanna Wardlaw, MD, professor of applied neuroimaging at the University of Edinburgh, discusses emerging imaging, blood-based, and functional biomarkers for tracking cerebral small vessel disease progression and evaluating treatment response. [WATCH TIME: 3 minutes]

2: World Stroke Day 2026: Closing the Gap Between Stroke Onset and the Emergency Call Number

In a recent Q&A interview, Brian Snelling, MD, director of the stroke program at Marcus Neuroscience Institute, discussed delays in calling 911 after stroke onset, gaps in awareness of atypical symptoms, and how to reach underserved populations.

3: Improving Manuscript Quality and Publication Success in Stroke Research: Bruce Ovbiagele, MD, MSc, MAS, MBA

In recent WSC 2026 interview, Bruce Ovbiagele, MD, MSc, MAS, MBA, editor-in-chief of the Journal of the American Heart Association, discusses what editors prioritize in research manuscripts, common submission mistakes, and strategies for improving publication readiness. [WATCH TIME: 4 minutes]

4: Collective Advocacy, Shared Priorities, and What’s Ahead at MDA 2027

In a recent Q&A interview, Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.

5: Investigating the Genetic Link Between EBV and MS Risk: David A. Hafler, MD, FANA; Yoshiaki Yasumizu, MD, PhD

In a recent MSToronto 2026 interview, neuroimmunology experts David A. Hafler, MD, FANA, and Yoshiaki Yasumizu, MD, PhD, of Yale School of Medicine, discussed new genetic and single-cell data linking Epstein-Barr virus persistence to multiple sclerosis risk genes. [WATCH TIME: 5 minutes]